Our Goal: to provide an easy, affordable and informative means for our customers to purchase home medical equipment and supplies from the comfort of their homes and medical offices.
Safety committee raises concern over ArQule's liver cancer drug
(Reuters) - Drugmaker ArQule Inc said a late-stage trial of its liver cancer drug showed high incidence of low white blood cell count in patients, leading to an independent safety committee recommending the company lower the drug dose.
No comments:
Post a Comment